Home Case Studies Revolutionizing Arthritis Trials with AI-Driven Imaging Biomarkers

Revolutionizing Arthritis Trials with AI-Driven Imaging Biomarkers

Multi-billion-dollar industry leader

The client needed a more accurate and automated solution to enable smaller, cost-efficient trials while maintaining regulatory confidence.

Meet our client

Client:

Multi-billion-dollar industry leader

Industry:

Healthcare / Pharma

Market:

Europe

Technology:

LLM

Client’s Challenge

Traditional radiographic assessments in arthritis trials were costly, variable, and not sensitive enough to reliably detect early structural damage. The client needed a more accurate and automated solution to enable smaller, cost-efficient trials while maintaining regulatory confidence.

Our Solution

We enabled data flow of manual radiographic readings for the development of AI/ML-based imaging biomarkers as automated, standardized, and more sensitive tools. The solution was built on an AWS cloud-based data lake, applying FAIR data principles and integrating automated image analysis models within the Collective Minds Radiology platform. To ensure adoption and scalability, we also established secure data-sharing frameworks in alignment with regulatory pathways.

Client’s Benefits

The solution reduces trial costs and variability while improving sensitivity and speed of structural damage assessment, enabling smaller, more efficient studies and faster regulatory submissions.

See more projects